Bull
$6.15
Scenario price
$5.670
+0.050 (+0.89%)At close
Banco Santander Brasil SA (Cayman Islands Branch) is a Cayman Islands-based company. The Company operated as a branch of Banco Santander Brasil SA in Brazil which provides commercial banking.
Banco Santander Brasil is not a strong buy right now due to its current price of $5.58 being close to its 52-week low and an RSI of 34.763, indicating potential oversold conditions. The stock has shown a 5-day change of -3.96% and a year-to-date change of -10.14%, reflecting a downward trend. However, the forward P/E ratio of 5.9844 suggests it may be undervalued compared to its earnings potential. The main risk is the downgrade from analysts due to a weak Q2 report, which has raised concerns about credit cycle risks.
HSBC
—
2026-09-15
HSBC
2026-09-15
Price Target
—
UBS
—
2026-08-24
UBS
2026-08-24
Price Target
—
UBS
—
2026-08-23
UBS
2026-08-23
Price Target
—
JPMorgan
$6
2026-07-30
JPMorgan
2026-07-30
Price Target
$6
JPMorgan
$7
2026-07-07
JPMorgan
2026-07-07
Price Target
$7
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Investor Perspectives on Multiple Companies

Mistral AI Secures €3 Billion Funding to Compete with OpenAI

European Banks Recover but Momentum Weakens

General Motors Secures $4.5 Billion Parts Agreement

Santander Brasil (BSBR) Q2 2026 Earnings Call Transcript
Banco Santander Brasil SA (Cayman Islands Branch) is a Cayman Islands-based company. The Company operated as a branch of Banco Santander Brasil SA in Brazil which provides commercial banking. It operates in the Financials sector.
Banco Santander Brasil is not a strong buy right now due to its current price of $5.58 being close to its 52-week low and an RSI of 34.763, indicating potential oversold conditions. The stock has shown a 5-day change of -3.96% and a year-to-date change of -10.14%, reflecting a downward trend. However, the forward P/E ratio of 5.9844 suggests it may be undervalued compared to its earnings potential. The main risk is the downgrade from analysts due to a weak Q2 report, which has raised concerns about credit cycle risks.
6 analysts cover BSBR: 1 rate it Buy, 3 Hold and 2 Sell.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.